$84.95
CJC-1295 (DAC) is a synthetic growth hormone–releasing hormone (GHRH) analog modified with a Drug Affinity Complex (DAC) to extend peptide stability in research environments. It is widely studied in in-vitro and preclinical laboratory models for its role in endocrine signaling and sustained receptor interaction dynamics.
In controlled research settings, CJC-1295 (DAC) is investigated for its interactions with GHRH receptors, prolonged signal transduction activity, and downstream neuroendocrine regulatory mechanisms associated with growth hormone pathway modulation.
Supplied as a high-purity lyophilized research reagent, this compound is intended exclusively for advanced laboratory research applications where peptide stability, analytical consistency, and reproducibility are required.
This product is supplied strictly as a research chemical for laboratory and in-vitro scientific use only.
Not for human or veterinary use.
25 in stock
Purity Guaranteed
Expert Customer Support
Fast & Secure Shipping
Secure Payment
Description
CJC-1295 (DAC) – 5 mg Research Peptide
NRG Peptide Kingdom
≥99% Purity | Research Use Only (RUO)
COA available for every batch
Fast Australia-wide dispatch
Secure encrypted checkout • Discreet, carefully packaged delivery
Product Overview
CJC-1295 (DAC) is a synthetic growth hormone–releasing hormone (GHRH) analog modified with a Drug Affinity Complex (DAC) to extend peptide stability in research environments. It is widely studied in in-vitro and preclinical laboratory models for its role in endocrine signaling and sustained receptor interaction dynamics.
In controlled research settings, CJC-1295 (DAC) is investigated for its interactions with GHRH receptors, prolonged signal transduction activity, and downstream neuroendocrine regulatory mechanisms associated with growth hormone pathway modulation.
Supplied as a high-purity lyophilized research reagent, this compound is intended exclusively for advanced laboratory research applications where peptide stability, analytical consistency, and reproducibility are required.
This product is supplied strictly as a research chemical for laboratory and in-vitro scientific use only.
Not for human or veterinary use.
Composition (per vial)
| Component | Amount |
|---|---|
| CJC-1295 (DAC) | 5 mg |
Total peptide content: 5 mg (lyophilized)
Key Features
-
5 mg lyophilized CJC-1295 (DAC) per vial
-
≥99% purity (HPLC-verified)
-
Research-grade modified GHRH analog
-
Drug Affinity Complex (DAC) for extended peptide stability in research models
-
Individually sealed sterile glass vial
-
Batch-specific Certificate of Analysis (COA) provided
-
Manufactured for advanced biochemical and endocrine signaling research
Intended Research Use
This product is supplied strictly for laboratory research use only (RUO).
Intended for:
-
Endocrine and neuroendocrine signaling research
-
GHRH receptor–ligand interaction studies
-
Sustained peptide signaling and pathway modeling
-
Peptide-mediated regulatory mechanism analysis
-
In-vitro biochemical and molecular biology experiments
Regulatory Notice
For laboratory research use only.
Not for human or veterinary administration.
Not approved by the TGA, FDA, EMA, or any regulatory authority for therapeutic or diagnostic use.
The purchaser assumes all responsibility for lawful handling, storage, and use.
